Oxygen for Vascular Incisional Healing
A Prospective, Randomized, Crossover Study of Transdermal, Continuous Oxygen Therapy for Surgical Site Wound Healing in High- Risk Subjects Undergoing Lower Extremity Revascularization
Sponsor: Neogenix, LLC dba Ogenix
Listed as NCT03746132, this NA trial focuses on Incision and Lower Extremity and remains ongoing. Sponsored by Neogenix, LLC dba Ogenix, it has been updated 9 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Oct 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Oct 2021 — Oct 2023 [monthly]
Recruiting NA
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Recruiting NA
-
Nov 2019 — Feb 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2019 — Nov 2019 [monthly]
Not Yet Recruiting NA
-
Dec 2018 — Sep 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Neogenix, LLC dba Ogenix
- University of Maryland, College Park
For direct contact, visit the study record on ClinicalTrials.gov .